These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

44 related articles for article (PubMed ID: 31858575)

  • 21. [Efficacy analysis of different pulmonary surfactants in premature infants with respiratory distress syndrome].
    Xu H; Xu P
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2021 Feb; 33(2):174-179. PubMed ID: 33729136
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Clinical efficacy of pulmonary surfactant combined with budesonide for preventing bronchopulmonary dysplasia in very low birth weight infants].
    Pan J; Chen MW; Ni WQ; Fang T; Zhang H; Chen Y; Pan JH
    Zhongguo Dang Dai Er Ke Za Zhi; 2017 Feb; 19(2):137-141. PubMed ID: 28202108
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of the SENP1-SIRT1 pathway in hyperoxia-induced alveolar epithelial cell injury.
    Dong W; Zhu X; Liu X; Zhao X; Lei X; Kang L; Liu L
    Free Radic Biol Med; 2021 Sep; 173():142-150. PubMed ID: 34311030
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A multicenter, randomized, controlled trial of lucinactant versus poractant alfa among very premature infants at high risk for respiratory distress syndrome.
    Sinha SK; Lacaze-Masmonteil T; Valls i Soler A; Wiswell TE; Gadzinowski J; Hajdu J; Bernstein G; Sanchez-Luna M; Segal R; Schaber CJ; Massaro J; d'Agostino R;
    Pediatrics; 2005 Apr; 115(4):1030-8. PubMed ID: 15805381
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Efficacy of different preparations of budesonide combined with pulmonary surfactant in the treatment of neonatal respiratory distress syndrome: a comparative analysis].
    Ke H; Li ZK; Yu XP; Guo JZ
    Zhongguo Dang Dai Er Ke Za Zhi; 2016 May; 18(5):400-4. PubMed ID: 27165587
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhalation or instillation of steroids for the prevention of bronchopulmonary dysplasia.
    Bassler D
    Neonatology; 2015; 107(4):358-9. PubMed ID: 26044104
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intratracheal Administration of Budesonide-Surfactant in Prevention of Bronchopulmonary Dysplasia in Very Low Birth Weight Infants: A Systematic Review and Meta-Analysis.
    Venkataraman R; Kamaluddeen M; Hasan SU; Robertson HL; Lodha A
    Pediatr Pulmonol; 2017 Jul; 52(7):968-975. PubMed ID: 28165675
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Review shows that using surfactant a number of times or as a vehicle for budesonide may reduce the risk of bronchopulmonary dysplasia.
    Hascoët JM; Picaud JC; Ligi I; Blanc T; Daoud P; Zupan V; Moreau F; Guilhoto I; Rouabah M; Alexandre C; Saliba E; Storme L; Patkai J; Pomedio M; Hamon I
    Acta Paediatr; 2018 Jul; 107(7):1140-1144. PubMed ID: 29193276
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhaled budesonide for the prevention of bronchopulmonary dysplasia.
    Bassler D
    J Matern Fetal Neonatal Med; 2017 Oct; 30(19):2372-2374. PubMed ID: 27756156
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy of porcine versus bovine surfactants for preterm newborns with respiratory distress syndrome: systematic review and meta-analysis.
    Singh N; Hawley KL; Viswanathan K
    Pediatrics; 2011 Dec; 128(6):e1588-95. PubMed ID: 22123870
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Update on Postnatal Corticosteroids to Prevent or Treat Bronchopulmonary Dysplasia.
    Filippone M; Nardo D; Bonadies L; Salvadori S; Baraldi E
    Am J Perinatol; 2019 Jul; 36(S 02):S58-S62. PubMed ID: 31238361
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Surfactant instillation in spontaneously breathing preterm infants: a systematic review and meta-analysis.
    Rigo V; Lefebvre C; Broux I
    Eur J Pediatr; 2016 Dec; 175(12):1933-1942. PubMed ID: 27678511
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Avoiding endotracheal ventilation to prevent bronchopulmonary dysplasia: a meta-analysis.
    Fischer HS; Bührer C
    Pediatrics; 2013 Nov; 132(5):e1351-60. PubMed ID: 24144716
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Animal derived surfactant extract for treatment of respiratory distress syndrome.
    Seger N; Soll R
    Cochrane Database Syst Rev; 2009 Apr; (2):CD007836. PubMed ID: 19370695
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association of Noninvasive Ventilation Strategies With Mortality and Bronchopulmonary Dysplasia Among Preterm Infants: A Systematic Review and Meta-analysis.
    Isayama T; Iwami H; McDonald S; Beyene J
    JAMA; 2016 Aug; 316(6):611-24. PubMed ID: 27532916
    [TBL] [Abstract][Full Text] [Related]  

  • 36. SIRT1-Related Signaling Pathways and Their Association With Bronchopulmonary Dysplasia.
    Yang K; Dong W
    Front Med (Lausanne); 2021; 8():595634. PubMed ID: 33693011
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Budesonide and Poractant Alfa prevent bronchopulmonary dysplasia via triggering SIRT1 signaling pathway.
    Du FL; Dong WB; Zhang C; Li QP; Kang L; Lei XP; Guo L; Zhai XS
    Eur Rev Med Pharmacol Sci; 2019 Dec; 23(24):11032-11042. PubMed ID: 31858575
    [TBL] [Abstract][Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.